Abstract
Previously, we reported that Toxoplasma gondii (T. gondii)-seropositivity is associated with higher impulsive sensation seeking in younger men. As dopaminergic and serotonergic signaling regulates impulsivity, and as T. gondii directly and indirectly affects dopaminergic signaling and induces activation of the kynurenine pathway leading to diversion of tryptophan from serotonin production, we investigated if dopamine and serotonin precursors or the tryptophan metabolite kynurenine interact with the T. gondii – impulsivity association. In 951 psychiatrically healthy participants, trait impulsivity scores were related to T. gondii IgG seropositivity. Interactions were also identified between categorized levels of phenylalanine (Phe), tyrosine (Tyr), Phe:Tyr ratio, kynurenine (Kyn), tryptophan (Trp) and Kyn:Trp ratio and age and gender. Only younger T. gondii-positive men with a high Phe:Tyr ratio were found to have significantly higher impulsivity scores. There were no significant associations in other demographic groups including older men and younger or older women. No significant effects or interactions were identified for Phe, Tyr, Kyn, Trp or Kyn:Trp ratio. Phe:Tyr ratio, therefore, may play a moderating role in the association between T. gondii seropositivity and impulsivity in younger men. These results could potentially lead to individualized approaches to reduce impulsivity based on combined demographic, biochemical and serological factors.
Keywords: Impulsivity, Toxoplasma gondii, phenylalanine, tyrosine, dopamine precursor, tryptophan, kynurenine, serotonin precursor
1. Introduction
The relationship between mental illness and inflammation has garnered increasing attention (Haroon et al., 2012; Najjar et al., 2013). Across serious mental illness including schizophrenia (Cotter et al., 2001; Potvin et al., 2008; Elsheikha and Zhu, 2016; Abdollahian et al., 2017; Fuglewicz et al., 2017), bipolar disorder (Cotter et al., 2001; Brietzke et al., 2011; Del Grande et al., 2017) and major depressive disorder (Cotter et al., 2001; Miller et al., 2009; Miller and Raison, 2016), immune changes, such as higher levels of proinflammatory cytokines, are commonly encountered biological signatures. Furthermore, signs of central inflammation such as microglial activation and elevated proinflammatory cytokine levels in the cerebrospinal fluid are linked to suicidal behavior (Janelidze et al., 2011; Bay-Richter et al., 2015; Brundin et al., 2015; Lund-Sorensen et al., 2016) and psychosis- or mood-related episode (McNally et al., 2008; Brietzke et al., 2011; Miller et al., 2011), and are linked to treatment responses for these conditions as well (McNally et al., 2008; Kubera et al., 2000; Miller et al., 2011; de Witte et al., 2014). In both human (Suarez, 2003; Suarez et al., 2004; Coccaro, 2006; Graham et al., 2006; Coccaro et al., 2014) and animal studies (Zalcman and Siegel, 2006; Bhatt et al., 2008; Patel et al., 2010; Pesce et al., 2011), behaviors commonly seen among those with mental illness, such as trait impulsivity (Moeller et al., 2001; Swann et al., 2009) and aggression (Oquendo et al., 2004; Soyka, 2011; Volavka and Citrome, 2011; Ballester et al., 2012), are also linked to higher levels of inflammation.
Toxoplasma gondii (T. gondii) (Dupont et al., 2012), similar with Herpesvidae family viruses (Nicholas, 2005; Jochum et al., 2012), is neurotropic pathogen that may result in low-grade immune activation due to increased rates of latent infection. Contrary to earlier beliefs that the sole presence of bradyzoites (i.e., slower growing forms) and tissue cysts during latent T. gondii was innocuous, research has shown a link between chronic toxoplasmosis and prominent psychiatric illnesses (Hinze-Selch et al., 2010; Tedla et al., 2011; Pearce et al., 2012; Torrey et al., 2012; Fond et al., 2013; Sutterland et al., 2015;) and suicidal behavior across diagnostic modalities (Arling et al., 2009; Yagmur et al., 2010; Ling et al., 2011; Okusaga et al., 2011; Pedersen et al., 2012; Zhang et al., 2012; Postolache and Cook, 2013; Ansari-Lari et al., 2017). As we have previously reported, trait impulsivity, considered an intermediate endophenotype for suicidal behavior (Turecki, 2005; Kovacsics et al., 2009; Mann et al., 2009), was positively associated with T. gondii seropositivity in younger (i.e., 20–59 years old) psychiatrically healthy men (Cook et al., 2015). Similarly, in psychiatric patients, T. gondii seropositivity has been associated with trait impulsivity and aggression, and with an Intermittent Explosive Disorder diagnosis (Coccaro et al., 2016). By contrast, a population-representative birth cohort study reported that suicide attempts were only marginally more frequent among individuals with T. gondii seropositivity (p = .06) (Sugden et al., 2016). The study finds no evidence of T. gondii relating to increased risk of psychiatric disorders or neurocognitive impairment either. Additionally, while most of the prior literature on psychiatric illnesses and T. gondii infection used T. gondii IgG antibodies for titer and seropositivity analysis, more recent literature has identified T. gondii IgM, but not IgG, antibody elevations in relationship with suicide attempts (Dickerson et al., 2017). A positive association between T. gondii IgG seropositivity and death by suicide vs. death due to other causes was identified postmortem, but only in the 38–58 age group (Samojlowicz et al., 2013). Of relevance, T.gondii seropositivity was higher in decedents with a positive blood alcohol test, both in those who died by suicide and those who died by other causes (Samojlowicz et al., 2013). Yet another study in Mexico found no association between T. gondii seropositivity and suicidal behavior but did confirm an association between the titers of IgG antibody and suicide attempts in psychiatric outpatients (Alvarado-Esquivel et al., 2013). Similar association of higher titers of T. gondii antibody and suicide attempt were reported too (Arling et al., 2009; Yagmur et al., 2010; Ling et al., 2011).
Dopaminergic neurotransmission is also involved in neurobiological aspects of impulsivity (van Gaalen et al., 2006; Dalley et al., 2007; Voon et al., 2010; Dalley and Roiser, 2012; Fernando et al., 2012; Costa et al., 2013; Djamshidian et al., 2013; Malloy-Diniz et al., 2013; Nandam et al., 2013; Simon et al., 2013; Mitchell and Potenza, 2014; Hamilton et al., 2015). Yet, there are conflicting findings regarding the direction of the association between impulsivity and dopaminergic function, with both direct associations reported by some (Cole and Robbins, 1989; Pezze et al., 2009; Eagle et al., 2011) and inverse associations presented by others (Oswald et al., 2007; Fernando et al., 2012; Kayser et al., 2012; Matuskey et al., 2013; Nandam et al., 2013; Chester et al., 2016). These heterogeneity may be a result of the complexity and specificity of dopamine receptor subtypes, and neural circuits involved in the dopamine neurotransmission (Oswald et al., 2007; Fernando et al., 2012; Kayser et al., 2012; Matuskey et al., 2013; Nandam et al., 2013; Chester et al., 2016). Additionally, impulsivity has been associated with genetic polymorphisms in enzymes associated with dopamine metabolic pathways, dopamine receptors and dopamine transporter activity (Ebstein et al., 1996; Retz et al., 2003; Bortolato and Shih, 2011; Malloy-Diniz et al., 2013; Chester et al., 2016). These moderating influences may also contribute to this variation.
Dopaminergic neurotransmission may play an important role in modulating behavioral changes including impulsivity in T. gondii infection. A microRNA study found that microRNA-132, a non-coding RNA involved in control of gene expression, is the microRNA that is substantially upregulated by all three-prototype T. gondii strains (Xiao et al., 2014). Moreover, in the same study, upregulation of microRNA-132 was found associated with changes in dopamine receptor signaling by decreasing expression of D1-like dopamine receptors, a dopamine receptor involved in the negative feedback regulation of dopamine release in the brain (Saklayen et al., 2004), and decreasing metabolizing enzyme (i.e., MAO-A). As a consequence, an increased level of dopamine might be expected. Indeed, microRNA-132 is upregulated and dopamine levels are elevated (by 38%) in striatal tissue of mice infected with T. gondii (Xiao et al., 2014). Similarly, other experimental studies also found that dopaminergic neurons containing T. gondii have demonstrated an increased synthesis of dopamine and an elevated presence of homovanillic acid, a dopamine metabolite (Stibbs, 1985; Prandovszky et al., 2011; Martin et al., 2015). A recent study reported a higher acoustic startle response magnitude among T. gondii infected participants (Massa et al., 2017). The authors proposed that the finding might be the outcome of increased dopamine production (Swerdlow et al., 1986; Parlog et al., 2015). Additionally, two genes that encode tyrosine (Tyr) hydroxylase, a rate-limiting enzyme of dopamine synthesis, were identified in the genome of T. gondii (Gaskell et al., 2009). The encoded enzymes metabolize phenylalanine (Phe), as well as Tyr with substrate preference for Tyr. Thus, the enzymes catabolize Phe to Tyr and Tyr to L-DOPA. To further support a T. gondii and dopamine connection, anti-dopaminergic agents prevent behavioral alterations induced by T. gondii in animals (Skallova et al., 2006; Webster et al., 2006). On the contrary, rats that have lower dopamine D2/D3 receptor availability in the ventral striatum display greater response impulsivity on the 5-choice serial-reaction time task, a laboratory behavioral task used to assess motor impulsivity in animals (Dalley et al., 2007). It was also reported that infection with T. gondii increases impulsivity in male rats with concomitant T. gondii infection caused reduction in dopamine level and neuronal spine density in the nucleus accumbens core (Tan et al., 2015). In summary, dopamine appears to be implicated in the association between T. gondii seropositivity and impulsivity, but the specifics of this interaction necessary to be targeted experimentally or therapeutically remain poorly understood.
The first step towards the synthesis of dopamine involves the conversion of the amino acid (i.e., Phe to Tyr) by activating Phe hydroxylase (PAH). It is followed by a two-part enzymatic reaction where Tyr is converted into dopamine via Tyr hydroxylase (the rate-limiting enzyme for biosynthesis of catecholamines) and L-type amino acid decarboxylase (van Spronsen et al., 2009; Daubner et al., 2011). The Phe and Tyr (Phe:Tyr) ratio, an estimate of PAH activity (Anderson et al., 1994), is higher in proinflammatory conditions including cancer (Neurauter et al., 2008a), trauma and sepsis (Ploder et al., 2008), human immunodeficiency virus infection (Zangerle et al., 2010) as well as depression (Hoekstra et al., 2001; Capuron et al., 2011) and schizophrenia (Rao et al., 1990; Wei et al., 1995; Okusaga et al., 2014). Oxidative stress and reactive oxygen species (ROS) induced depletion of (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4), an essential co-factor for PAH, may mediate, at least in part, the association between the Phe:Tyr ratio and Type 1 T-helper cell (Th1) immunity (Anderson et al., 1994; Werner et al., 2011). A high Phe:Tyr ratio, resulting from a dysfunction of PAH (Neurauter et al., 2008b; Capuron et al., 2011), can be the consequence of Th1 activation, which is known to be one of the protective immune mechanisms responsive to T. gondii infection (Spellberg and Edwards, 2001).
Based on the overriding hypothesis that dopamine neurotransmission may moderate the relationship between T. gondii seropositivity and impulsivity, we investigated how Phe, Tyr, and their ratio interact with T. gondii seropositivity in predicting impulsivity traits.
Low grade immune activation controls T. gondii and maintains the latency of chronic infection in the immunocompetent host, but a consequence of this is activation of the enzyme indoleamine 2,3-dioxygenase 1 (IDO-1) (Pfefferkorn, 1984; Nagineni et al., 1996; Fujigaki et al., 2002; Silva et al., 2002) resulting in a bias in the metabolism of the amino acid Trp toward the kynurenine (Kyn) pathway, at the detriment of serotonin synthesis. As Kyn inversely regulates dopamine function in the brain (Wu et al., 2007; Okuno et al., 2011; Linderholm et al., 2016;), and as T. gondii also activates the Kyn pathway leading to diverting tryptophan (Trp) from production of serotonin (Silva et al., 2002), another key neurotransmitter in impulsivity regulation (Kruesi et al., 1990; Dolan et al., 2001; Paaver et al., 2007; Xu et al., 2017), we also analyzed how Kyn, Trp, and their ratio interact with T. gondii seropositivity in predicting impulsivity traits.
2. Materials and methods
2.1. Sample
As part of a case-control study of schizophrenia, 951 healthy adults were recruited from Munich, Germany. After presenting participants with the study procedures, each participant completed a written informed consent form. The study was approved by the committee of local ethics of Ludwig Maximilians University, Munich, Germany. Additionally, the study was given exempt status from the University of Maryland IRB as data were de-identified and no further contact with participants was planned. Participants had no prior history of suicide attempts. Moreover, the Structured Clinical Interview or Diagnostic and Statistical Manual of Mental Disorders 4th Edition Text Revision (DSM-IV-TR) (First MB, 2002) was used to ascertain the exclusion of Axis I or II diagnoses in the sample. Blood samples were collected from a forearm vein into ethylenediaminetetraacetic acid (EDTA)-containing flasks, with no fasting protocols or dietary restrictions observed. The plasma acquired after 10 minutes of centrifuging samples at 4°C was aliquoted into Eppendorf tubes and stored at −80°C.
2.2. Measurement of plasma phenylalanine, tyrosine, kynurenine, and tryptophan
Plasma Phe, Tyr, Kyn and Trp levels were measured using high performance liquid chromatography (HPLC) with fluorescence detection, using 3-nitro-L-tyrosine as an internal standard, as described elsewhere (Neurauter et al., 2013; Okusaga et al., 2014).
2.3. T. gondii serological analysis
We used solid phase enzyme-linked imunosorbent assay (ELISA) to measure Immunoglobulin G (IgG) to T. gondii (Arling et al., 2009) (T. gondii IgG ELISA, IBL Laboratories, Hamburg, Germany). Using a human IgG-specific secondary enzyme-conjugated antibody, we identified particular antibodies bound to T. gondii antigens on the wells of the microtiter plates in the diluted serum once it had been exposed to the restrained antigens on the wells. A quantitative measurement of antibodies, involving optical density ratios of blood sample to a standard of 10 international units of anti-T. gondii antibody determined serointensity following the substrate reaction. Seropositivity was described by a titer greater than or equal to 0.8.
2.4. Measures of impulsivity
The Disinhibition subscale of the Sensation Seeking Scale-V [SSS-V(DIS)] (Zuckerman and Neeb, 1979), a valid and reliable measure consisting of 40 items of forced-choice, was used to estimate trait sensation-seeking impulsivity. The SSS-V was designed to assess individual differences in arousal and stimulation needs (Zuckerman, 1994; Roberti et al., 2003). Of the four SSS-V subscales, SSS-V(DIS) has shown the strongest correlation with reckless behavior (Trimpop et al., 1998; Jonah et al., 2001; Roberti, 2004) and risky driving (Constantinou et al., 2011). In previous studies, the SSS-V(DIS) subscale was used to measure impulsivity in the association between T. gondii and the risk of accidents caused by motor vehicle (Flegr et al., 2002; Yereli et al., 2006; Kocazeybek et al., 2009). Additionally, the sub-scale SSS-V(DIS) has been linked to elevated aggression (Wilson and Scarpa, 2013) and recurrent suicide attempts (Laget et al., 2006). Furthermore, the SSS-V(DIS) sub-scale has been associated with repeated suicide attempts (Laget et al., 2006) and higher levels of aggression (Wilson and Scarpa, 2013).
2.5. Variable transformations
The subjects were stratified into two age categories (i.e., older and younger) based on the median age (60 years old). Individuals who were 20–59 years old fell into the younger category, while individuals 60 years old and above were in the older category. We transformed levels of the molecular markers of the Phe-Tyr and the Trp-Kyn pathways into categorical variables (i.e., LOW and HIGH) according to prior published protocols (Okusaga et al., 2016). For the Phe:Tyr ratio, Phe, Kyn:Trp and Kyn, we considered all individuals with values in the lower 3 quartiles (i.e., lower 75%) as LOW and all individuals with a ratio falling in the upper quartile (i.e., top 25%) as HIGH. For Trp and Tyr, we considered all individuals with levels in the higher 3 quartiles (i.e., top 75%) as HIGH and all individuals with a ratio falling in the lowest quartile (i.e., lower 25%) as LOW.
2.6. Statistical analyses
An analysis of co-variance (ANCOVA) was performed in SYSTAT 13 to estimate the interactions of Phe level, Tyr level, and Phe:Tyr ratio on one hand, and Kyn, Trp and Kyn:Trp ratio on the other hand, with T. gondii seropositivity status in predicting impulsivity scores [i.e., SSS-V(DIS) scores). Covariates included age and gender. We also considered using BMI and education as covariates. BMI, however, did not correlate with impulsivity scores. Additionally, multivariate models with only age, gender and education as independent variables and impulsivity scores rendered education non-significant. The final model, thus, included T. gondii, monoamine precursors or ratios, age and gender. Further pairwise comparisons between means were performed using the post hoc Tukey’s Honestly-Significant-Difference test only after identifying statistically significant overall interactions of the multivariable models.
3. Results
Similar to previously published seroprevalence patterns of T. gondii in German populations (Pappas et al., 2009; Hinze-Selch et al., 2010), almost half of our sample of 950 psychiatrically normal individuals (n=476, 52.2%) were T. gondii seropositive (Table 1). The mean age of the sample was 53.6 (±15.8) years old. T. gondii positive participants were significantly older (59.1± 12.5) than T.gondii negative patients (48.1 ± 16.8, p<0.001). The mean Phe:Tyr ratio of T. gondii positive individuals was significantly lower than that of individuals who were T. gondii negative (p<0.001). The mean Phe level of T. gondii positive individuals was significantly lower than that of individuals who were T. gondii negative (p=0.019) but the mean Tyr level of T. gondii positive individuals had no significant difference from that of individuals who were T. gondii negative (p=0.531).
Table 1:
Characteristics of study sample (n=950) by T. gondii status
T. gondii IgG +a n=476 (52.2) |
T. gondii IgG − n=474 (47.8) |
Total n=950 |
p valueb | |
---|---|---|---|---|
Age mean± SD | 59.10± 12.50 | 48.10±16.80 | 53.60±15.80 | p=0.001 |
Sex n (%) | ||||
Male | 243 (51.0) | 220 (46.4) | 463 (48.7) | p=0.153 |
Female | 233 (48.9) | 254 (53.6) | 487 (51.3) | |
SSS-V(DIS) meaniSD | 12.02±1.75 | 12.34±1.88 | 12.18±1.82 | p=0.007 |
cPhe:Tyr mean±SD | 0.73±0.31 | 0.82±0.39 | 0.80 ±0.57 | p=0.001 |
Phe mean±SD (micromolar) | 67.24±49.21 | 75.05±53.78 | 71.20±51.70 | p=0.019 |
Tyr mean±SD (micromolar) | 87.66±51.35 | 89.56±42.49 | 88.62±47.05 | p=0.531 |
dKyn:Trp mean±SD | 44.05±30.96 | 37.82±22.71 | 40.93±27.31 | p<0.001 |
Kyn mean±SD (micromolar) | 2.48±1.12 | 2.30±1.28 | 2.39±1.21 | p=0.022 |
Trp mean±SD (micromolar) | 65.28±31.88 | 65.58±24.01 | 65.43±28.20 | p=0.87 |
SSS-V(DIS): The scores of disinhibition subscale of the Sensation Seeking Scale-V
T. gondii = Toxoplasma gondii
The numbers in the parentheses in the table are percentages
IgG = immunoglobulin G serum antibody status, tested by ELISA
T. gondii IgG+: Toxoplasma gondii seropositivity was defined by an IgG titer greater than or equal to 0.8
Statistical tests using t-test for continuous and Chi-square test for categorical variables
Phe:Tyr = ratio between plasma phenylalanine (Phe) and tyrosine (Tyr) levels
Kyn:Trp = ratio between plasma kynurenine (Kyn) and tryptophan (Trp) levels
The mean Kyn:Trp ratio (p<0.001) and Kyn level (p=0.022) of T. gondii positive individuals were significantly different from these of individuals who were T. gondii negative. No significant difference was found in the mean Trp level between T. gondii positive and negative groups (p=0.87).
An ANCOVA on the impulsivity scores showed significant interaction among T. gondii seropositivity, Phe:Tyr ratio categories, and gender and age categories (F(1,896) = 7.772, p = 0.007). We therefore further ran an ANCOVA on the impulsivity scores in different gender and age groups. The result yielded a significant interaction between T. gondii seropositivity status and Phe:Tyr ratio category (F(1,173) = 10.635, p = 0.001) that was evident only in younger men.
A post-hoc Tukey’s Honestly-Significant-Difference test indicated that statistically significant differences in the impulsivity scores between seropositive and negative individuals were only present in younger men (aged 20 to 59 years) who also had high Phe:Tyr ratios (i.e., ratios that fell into the top quartile). Specifically in the high Phe:Tyr ratio group, the mean adjusted difference in impulsivity scores was 2.50 points higher in seropositive as compared to seronegative younger men (CI = 0.98 to 4.02, p < 0.001) (Figure 1A). Further, in seropositive younger men, mean adjusted impulsivity scores in those who had high Phe:Tyr ratios were also 1.87 points higher than in individuals with low Phe:Tyr ratios (95% CI = 0.43 to 3.31, p = 0.006). In individuals categorized as having LOW Phe:Tyr ratios, no significant differences were observed in impulsivity scores between individuals in the two seropositivity categories (p = 0.847, 95% CI = −0.555 to 1.105) (Figure 1A).
Fig. 1.
Comparisons of impulsivity scores between T. gondii IgG-seropositive versus seronegative subjects, stratified by age groups, gender, and blood Phenylalanine/Tyrosine ratio (Phe: Tyr) categories.
Impulsivity scores in seropositive vs. seronegatives participants stratified by gender, age and Phe: Tyr categories. Strata include younger women (aged 20 to 59 years), older women (aged 60 years and up), younger men (aged 20 to 59 years), and older men (aged 60 years and up). Phe:Tyr ratio was categorized as HIGH if the ratio fell in top 25th percentile, and was categorized as LOW if the ratio fell in lower 75th percentile. Impulsivity Scores on the Disinhibition subscale of the Sensation Seeking Scale-V [SSS-V(DIS)] are presented as least square means and standard errors (SEs), stratified by categorical variable and adjusted for age within the age category. ANCOVA analysis of impulsivity scores showed statistically significant interactions between T. gondii seropositivity, Phe:Tyr ratio, gender and age category (F(1,896) = 7.772, p = 0.007). A significant interaction between T. gondii seropositivity status and Phe:Tyr ratio was significant in younger men (F(1,173) = 10.635, p = 0.001), but not in older men (F(1,256) = 0.593, p = 0.442), younger women (F(1,280) = 0.516, p = 0.473), and older women (F(1,184) = 1.868, p = 0.173).
* Tukey’s Honestly Significant Difference Test showed that the impulsivity score in younger men, who were also T. gondii seropositive and had HIGH Phe:Tyr ratios, were signifificantly higher than in all other subgroups (p < 0.01 for all), with no other significant differences between subgroups.
There were no significant interactions found between T. gondii seropositivity and Phe:Tyr ratio category in all other gender and age groups including older men (F(1,256) = 0.593, p = 0.442; Figure 1B), younger women (F(1,280) = 0.516, p = 0.473), and older women (F(1,184) = 1.868, p = 0.173).
There were no significant interactions of categorical Phe (F(1,896) = 1.901, p = 0.168) or Tyr (F(1,896) = 0.695, p = 0.405) and T. gondii seropositivity status, gender and age category.
There were no significant interactions between T. gondii seropositivity and categorical Kyn, Trp and their ratio. Specifically, categorical Kyn:Trp ratio (F(1,913) = 0.39, p = 0.532), Kyn (F(1,913) = 1.913, p = 0.167), and Trp (F(1,913) = 0.166, p = 0.684) showed no significant interactions in a model including T. gondii seropositivity, gender and age category.
4. Discussion
Our findings demonstrated increased trait impulsivity scores only in individuals who met four criteria - being men, younger (i.e., 20–59 years old), T. gondii seropositive, and having Phe:Tyr ratios in the upper quartile. To our knowledge, this is the first study regarding the moderation by Phe:Tyr ratio of the association between T. gondii seropositivity and trait impulsivity. This complements our recent publication on a positive correlation between Phe:Tyr ratio and trait aggression in T. gondii-positive men (Mathai et al., 2016). Changes in dopaminergic signaling may mediate current results.
Supporting a direct role of dopamine in modulating impulsivity, systemic use of dopamine D2-like receptor agonists has been reported to reduce response impulsivity in rats (Fernando et al., 2012) and in human healthy controls (Nandam et al., 2013). Additionally, administration of the dopamine D2/D3 receptor antagonist haloperidol in smokers results in increased motor impulsivity (i.e., reduced accuracy) and reduced activation in the prefrontal regions associated with inhibitory control (Luijten et al., 2013). Administration of the dopamine D2/D3 receptor antagonist nafadotride into the accumbens shell in rats also enhances premature responding in high impulsive rats (Besson et al., 2010). Moreover, highly impulsive rats display low dopamine D2-like receptor mRNA expression in the mesolimbic pathway (Besson et al., 2013). In human subjects, dopamine D2/D3 receptor availability also negatively correlates with impulsivity and positively correlates with inhibition-related fMRI activation in frontostriatal circuitry (Ghahremani et al., 2012). Specifically, rats that have lower dopamine D2/D3 receptor availability in the ventral striatum (more specifically the nucleus accumbens) display greater response impulsivity on a motor impulsivity animal model (Dalley et al., 2007). Furthermore, cerebrospinal fluid homovanillic acid, the main metabolite of dopamine, correlates negatively with impulsive aggression (Coccaro and Lee, 2010), which is supportive of decreased levels of dopaminergic activity in impulsive behaviors. Beside those findings supporting an inverse association between impulsivity and dopaminergic function, there are findings suggesting a direct association between them as well (Cole and Robbins, 1989; Pezze et al., 2009; Eagle et al., 2011). The explanation for the variation was discussed in introduction. Nonetheless, those findings support that dopaminergic neurotransmission plays an important role in the neurobiological aspects of impulsivity.
The rate limiting step of dopamine formation is the conversion of Tyr into dopamine via Tyr hydroxylase, which is followed by L-type amino acid decarboxylase (van Spronsen et al., 2009; Daubner et al., 2011). Interestingly, the genome of T. gondii includes genes that encode Tyr hydroxylase is also activated in the tissue cyst (bradyzoite, chronic) stage (Gaskell et al., 2009). Correspondingly, dopaminergic neurons containing T. gondii have demonstrated an increased synthesis of dopamine (Stibbs, 1985; Prandovszky et al., 2011; Xiao et al., 2014; Martin et al., 2015). Our study found that a higher host Phe:Tyr ratio, but not significantly changed individual Tyr or Phe level, is associated with an increased impulsivity in younger men who are T. gondii seropositive. The higher host Phe:Tyr ratio may result from a decreased PAH activity (Neurauter et al., 2008; Capuron et al., 2011). The implicated decreases in PAH activity can be secondary to Th1 immune activation in the brain that is necessary to contain T. gondii infection in the immunocompetent host (Spellberg and Edwards, 2001). Therefore, the relatively lower Tyr availability can be a consequence of low grade immune activation induced and perpetuated by T. gondii chronic infection. Moreover, while dopaminergic neurons infected by T. gondii have demonstrated increased synthesis of dopamine (Stibbs, 1985; Prandovszky et al., 2011; Xiao et al., 2014; Martin et al., 2015), an in vivo study demonstrated that the spread of T. gondii does not have a preference towards a particular functional system nor towards the dopaminergic brain tissue (Berenreiterova et al., 2011; McConkey et al., 2013). This may cause aberrant dopamine production in non-dopaminergic brain loci. Consequently, the relatively lower Tyr availability would be further accentuated by parasite through diversion of Tyr from normal dopaminergic neurons to the non-dopaminergic neurons. This may worsen the relative Tyr deficits in the dopaminergic brain tissue and dopaminergic tissues outside of central nervous system which are not directly infected with T. gondii (Kaufman, 1971; Di Cristina et al., 2008).
We speculated that immune activation may be the key ingredient contributing to our results. However, if this were so, considering the upregulation of IDO-1 by immune activation, we would have expected to see similarities between Phe:Tyr and Kyn:Trp ratios in interacting with T. gondii in predicting impulsivity (Capuron et al., 2011). This however was not the case as there were no significant effects in impulsivity scores and interactions in a model including T. gondii seropositivity and Kyn:Trp. Furthermore, arguing against an immune hypothesis, in our recent study, we have identified an association between IED (and trait impulsivity in IED) and T. gondii seropositivity, but the association did not appear to be mediated by levels of IL-6 (Coccaro et al., 2016). However, we cannot rule out the role of other cytokines including interferon gamma and tumor necrosis factor, which act to restrain T. gondii (Pfefferkorn, 1984; Nagineni et al., 1996; Fujigaki et al., 2002; Silva et al., 2002). It is also possible that the proinflammatory processes keeping T. gondii latent are limited to the central nervous system, so that the changes in IL-6 levels are not observed in peripheral blood circulation. Our finding also suggests dopaminergic activity may play a more impactful role than serotonergic activity in increased trait impulsivity scores in T. gondii seropositive younger men.
Sex differences in the effects of dopamine activity on impulsivity have been recently uncovered in rodents. Specifically, dopamine D2 receptor antagonism decreases advantageous responding (i.e, increased impulsivity) in male rats, whereas dopamine D2 receptor agonist decreases advantageous responding in female rats (Georgiou et al. 2018). In our earlier work, we identified higher reactive aggression scores in T. gondii positive women and higher impulsivity scores in younger men (Cook et al., 2015), which were further expanded by our current finding. These are consistent with previously reported gender differences in linking T. gondii seropositivity and measures of personality (Flegr et al., 1996; Flegr et al., 2000; Lindova et al., 2006; Flegr, 2007; Flegr et al., 2008; Lindova et al., 2010; Fond et al., 2013; Tan et al., 2015; Tan and Vyas, 2016).
Longitudinal studies will have the capability to elucidate directions of causality, mediations, moderation and effect modifications by demographic, clinical, serological and biochemical markers presented in our manuscript. In particular, clinical trials with interventions targeting T. gondii infection, inflammation and Phe and Tyr levels (particularly Phe:Tyr ratio) could be tailored for specific subgroups. The subgroups should include younger men with a variety of conditions associated with high impulsivity (Moeller et al., 2001; Sharma et al., 2014), potentially leading to violence towards self or others. Specifically, alcohol use disorder can be one of such conditions, given there are a robust associations between alcohol use and impulsivity (Allen et al., 1998; Brady et al., 1998; Bechara, 2005; Perry and Carroll, 2008; Czapla et al., 2015), self-directed violence (Pompili et al., 2010), as well as T. gondii seropositivity (Samojlowicz et al., 2013).
Our study has multiple limitations. No causal relationships between impulsivity in T. gondii positive individuals and catecholamine precursors can be concluded because of the cross-sectional design of this study and the absence of immune marker measurements. Opportunities to measure dopamine metabolites were not pursued, considering that the primary study had other, unrelated, aims. Fasting protocols, dietary regimens and timing of meals, which may be relevant (Wurtman et al., 1968), were not obtained. Moreover, trait impulsivity responses on questionnaires were not corroborated with personal history and neuropsychological testing of impulsivity.
Despite the aforementioned limitations, this study possessed important strengths. We studied a large sample size of healthy individuals, in which psychopathology was ruled out methodically using SCID for DSM-IV-TR. Thus, we avoided confounding variables related to mental illness (e.g., their symptoms, functional impairments, ongoing treatment and treatment changes).
In conclusion, as trait impulsivity is considered an endophenotype of suicidal behavior (Mann et al., 2009), our data suggest potential for individualized interventions to prevent suicide based on certain intersections of clinical, demographic, psychological, and laboratory markers.
Highlights.
Toxoplasma gondii (T. gondii) was previously associated with higher impulsivity.
Dopaminergic system regulates impulsivity, and T. gondii secretes dopamine (DA).
DA precursors (phenylalanine [Phe]; tyrosine [Tyr]) change with mild inflammation.
We measured and related T. gondii, Phe, Tyr and impulsivity in healthy subjects.
Only young men with both high Phe:Tyr and T.gondii (+) reported high impulsivity.
Acknowledgement:
The authors thank Aline Dagdag, Winny Mwaura, Afshan Qureshi, and James Honemond, and Dr. Aamar Sleemi and for their assistance throughout the project.
Funding:
This work was supported by a Distinguished Investigator Award from the American Foundation for Suicide Prevention (DIG 1-162-12, PI Postolache, co PI Rujescu); with additional funding from the P30 DK072488 NIDDK (NORC pilot/developmental grant, PI Postolache) from the National Institutes of Health, Bethesda, MD, the Rocky Mountain MIRECC for Suicide Prevention, Denver, CO (Brenner, Lowry, Postolache), and University of Maryland, Joint Institute for Food Safety and Applied Nutrition and the U.S. Food and Drug Administration (or U.S. FDA) for their support through the cooperative agreement FDU.001418 (subproject PI Postolache). Additional support for the writing of this manuscript was received from grants 1 I01 CX001310–01 from CSR&D/Veterans Affairs Administration (Merit Award, PI Postolache). Stanley Laboratory of Developmental Neurovirology, Baltimore, Maryland conducted the measurements of T. gondii antibodies. No funding source played any role in the design and conduct of the study, in data collection, management, analysis, and interpretation of the data, and preparation, review and approval of the manuscript. The findings and conclusions in this study are those of the authors and do not necessarily represent the view of the NIH, FDA, VA or the United States Government.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- Abdollahian E, Shafiei R, Mokhber N, Kalantar K, Fata A, 2017. Seroepidemiological Study of Toxoplasma gondii Infection among Psychiatric Patients in Mashhad, Northeast of Iran. Iran J Parasitol 12 (1), 117–122. [PMC free article] [PubMed] [Google Scholar]
- Allen TJ, Moeller FG, Rhoades HM, Cherek DR, 1998. Impulsivity and history of drug dependence. Drug Alcohol Depend 50 (2), 137–145. [DOI] [PubMed] [Google Scholar]
- Alvarado-Esquivel C, Sanchez-Anguiano LF, Arnaud-Gil CA, Lopez-Longoria JC, Molina-Espinoza LF, Estrada-Martinez S, Liesenfeld O, Hernandez-Tinoco J, Sifuentes-Alvarez A, Salas-Martinez C, 2013. Toxoplasma gondii infection and suicide attempts: a case-control study in psychiatric outpatients. J Nerv Ment Dis 201 (11), 948–952. [DOI] [PubMed] [Google Scholar]
- Anderson DN, Wilkinson AM, Abou-Saleh MT, Blair JA, 1994. Recovery from depression after electroconvulsive therapy is accompanied by evidence of increased tetrahydrobiopterin-dependent hydroxylation. Acta Psychiatr Scand 90 (1), 10–13. [DOI] [PubMed] [Google Scholar]
- Ansari-Lari M, Farashbandi H, Mohammadi F, 2017. Association of Toxoplasma gondii infection with schizophrenia and its relationship with suicide attempts in these patients. Trop Med Int Health 22 (10), 1322–1327. [DOI] [PubMed] [Google Scholar]
- Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, Balis T, Cabassa JA, Scrandis DA, Tonelli LH, Postolache TT, 2009. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 197 (12), 905–908. [DOI] [PubMed] [Google Scholar]
- Ballester J, Goldstein T, Goldstein B, Obreja M, Axelson D, Monk K, Hickey M, Iyengar S, Farchione T, Kupfer DJ, Brent D, Birmaher B, 2012. Is bipolar disorder specifically associated with aggression? Bipolar Disord 14 (3), 283–290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bay-Richter C, Linderholm KR, Lim CK, Samuelsson M, Traskman-Bendz L, Guillemin GJ, Erhardt S, Brundin L, 2015. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav Immun 43, 110–117. [DOI] [PubMed] [Google Scholar]
- Bechara A, 2005. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci 8 (11), 1458–1463. [DOI] [PubMed] [Google Scholar]
- Berenreiterova M, Flegr J, Kubena AA, Nemec P, 2011. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS One 6 (12), e28925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Besson M, Belin D, McNamara R, Theobald DE, Castel A, Beckett VL, Crittenden BM, Newman AH, Everitt BJ, Robbins TW, Dalley JW, 2010. Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens. Neuropsychopharmacology 35 (2), 560–569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Besson M, Pelloux Y, Dilleen R, Theobald DE, Lyon A, Belin-Rauscent A, Robbins TW, Dalley JW, Everitt BJ, Belin D, 2013. Cocaine modulation of frontostriatal expression of Zif268, D2, and 5-HT2c receptors in high and low impulsive rats. Neuropsychopharmacology 38 (10), 1963–1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bhatt S, Bhatt R, Zalcman SS, Siegel A, 2008. Role of IL-1 beta and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat. Brain Behav Immun 22 (2), 224–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bortolato M, Shih JC, 2011. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol 100, 13–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brady KT, Myrick H, McElroy S, 1998. The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am J Addict 7 (3), 221–230. [PubMed] [Google Scholar]
- Brietzke E, Stabellini R, Grassi-Oliveira R, Lafer B, 2011. Cytokines in bipolar disorder: recent findings, deleterious effects but promise for future therapeutics. CNS Spectr 16 (7), 157–168. [DOI] [PubMed] [Google Scholar]
- Brundin L, Erhardt S, Bryleva EY, Achtyes ED, Postolache TT, 2015. The role of inflammation in suicidal behaviour. Acta Psychiatr Scand 132 (3), 192–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Capuron L, Schroecksnadel S, Feart C, Aubert A, Higueret D, Barberger-Gateau P, Laye S, Fuchs D, 2011. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry 70 (2), 175–182. [DOI] [PubMed] [Google Scholar]
- Chester DS, DeWall CN, Derefinko KJ, Estus S, Lynam DR, Peters JR, Jiang Y, 2016. Looking for reward in all the wrong places: dopamine receptor gene polymorphisms indirectly affect aggression through sensation-seeking. Soc Neurosci 11 (5), 487–494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coccaro EF, 2006. Association of C-reactive protein elevation with trait aggression and hostility in personality disordered subjects: a pilot study. J Psychiatr Res 40 (5), 460–465. [DOI] [PubMed] [Google Scholar]
- Coccaro EF, Lee R, 2010. Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: reciprocal relationships with impulsive aggression in human subjects. J Neural Transm (Vienna) 117 (2), 241–248. [DOI] [PubMed] [Google Scholar]
- Coccaro EF, Lee R, Coussons-Read M, 2014. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry 71 (2), 158–165. [DOI] [PubMed] [Google Scholar]
- Coccaro EF, Lee R, Groer MW, Can A, Coussons-Read M, Postolache TT, 2016. Toxoplasma gondii infection: relationship with aggression in psychiatric subjects. J Clin Psychiatry 77 (3), 334–341. [DOI] [PubMed] [Google Scholar]
- Cole BJ, Robbins TW, 1989. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33 (2), 165–179. [DOI] [PubMed] [Google Scholar]
- Constantinou E, Panayiotou G, Konstantinou N, Loutsiou-Ladd A, Kapardis A, 2011. Risky and aggressive driving in young adults: Personality matters. Accid Anal Prev 43 (4), 1323–1331. [DOI] [PubMed] [Google Scholar]
- Cook TB, Brenner LA, Cloninger CR, Langenberg P, Igbide A, Giegling I, Hartmann AM, Konte B, Friedl M, Brundin L, Groer MW, Can A, Rujescu D, Postolache TT, 2015. “Latent” infection with Toxoplasma gondii: association with trait aggression and impulsivity in healthy adults. J Psychiatr Res 60, 87–94. [DOI] [PubMed] [Google Scholar]
- Costa A, la Fougere C, Pogarell O, Moller HJ, Riedel M, Ettinger U, 2013. Impulsivity is related to striatal dopamine transporter availability in healthy males. Psychiatry Res 211 (3), 251–256. [DOI] [PubMed] [Google Scholar]
- Cotter DR, Pariante CM, Everall IP, 2001. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 55 (5), 585–595. [DOI] [PubMed] [Google Scholar]
- Czapla M, Simon JJ, Richter B, Kluge M, Friederich HC, Herpertz S, Mann K, Herpertz SC, Loeber S, 2015. The impact of cognitive impairment and impulsivity on relapse of alcohol-dependent patients: implications for psychotherapeutic treatment. Addict Biol. [DOI] [PubMed] [Google Scholar]
- Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, Pena Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW, 2007. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315 (5816), 1267–1270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dalley JW, Roiser JP, 2012. Dopamine, serotonin and impulsivity. Neuroscience 215, 42–58. [DOI] [PubMed] [Google Scholar]
- Daubner SC, Le T, Wang S, 2011. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508 (1), 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S, 2014. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res 154 (1–3), 23–29. [DOI] [PubMed] [Google Scholar]
- Del Grande C, Galli L, Schiavi E, Dell’Osso L, Bruschi F, 2017. Is Toxoplasma gondii a Trigger of Bipolar Disorder? Pathogens 6 (1). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Di Cristina M, Marocco D, Galizi R, Proietti C, Spaccapelo R, Crisanti A, 2008. Temporal and spatial distribution of Toxoplasma gondii differentiation into Bradyzoites and tissue cyst formation in vivo. Infect Immun 76 (8), 3491–3501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dickerson F, Wilcox HC, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C, Schweinfurth L, Stallings C, Sweeney K, Yolken R, 2017. Suicide attempts and markers of immune response in individuals with serious mental illness. J Psychiatr Res 87, 37–43. [DOI] [PubMed] [Google Scholar]
- Djamshidian A, O’Sullivan SS, Foltynie T, Aviles-Olmos I, Limousin P, Noyce A, Zrinzo L, Lees AJ, Averbeck BB, 2013. Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson’s disease. J Parkinsons Dis 3 (2), 139–144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dolan M, Anderson IM, Deakin JF, 2001. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. Br J Psychiatry 178, 352–359. [DOI] [PubMed] [Google Scholar]
- Dupont CD, Christian DA, Hunter CA, 2012. Immune response and immunopathology during toxoplasmosis. Semin Immunopathol 34 (6), 793–813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eagle DM, Wong JC, Allan ME, Mar AC, Theobald DE, Robbins TW, 2011. Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J Neurosci 31 (20), 7349–7356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH, 1996. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet 12 (1), 78–80. [DOI] [PubMed] [Google Scholar]
- Elsheikha HM, Zhu XQ, 2016. Toxoplasma gondii infection and schizophrenia: an inter-kingdom communication perspective. Curr Opin Infect Dis 29 (3), 311–318. [DOI] [PubMed] [Google Scholar]
- Fernando AB, Economidou D, Theobald DE, Zou MF, Newman AH, Spoelder M, Caprioli D, Moreno M, Hipolito L, Aspinall AT, Robbins TW, Dalley JW, 2012. Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology (Berl) 219 (2), 341–352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- First MBS, Robert L, Gibbon Miriam, and Williams, Janet BW, 2002. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version,
- Flegr J, 2007. Effects of toxoplasma on human behavior. Schizophr Bull 33 (3), 757–760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z, 2002. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect Dis 2, 11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flegr J, Kodym P, Tolarova V, 2000. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol Psychol 53 (1), 57–68. [DOI] [PubMed] [Google Scholar]
- Flegr J, Lindova J, Kodym P, 2008. Sex-dependent toxoplasmosis-associated differences in testosterone concentration in humans. Parasitology 135 (4), 427–431. [DOI] [PubMed] [Google Scholar]
- Flegr J, Zitkova S, Kodym P, Frynta D, 1996. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 113 (Pt 1), 49–54. [DOI] [PubMed] [Google Scholar]
- Fond G, Capdevielle D, Macgregor A, Attal J, Larue A, Brittner M, Ducasse D, Boulenger JP, 2013. Toxoplasma gondii: a potential role in the genesis of psychiatric disorders. Encephale 39 (1), 38–43. [DOI] [PubMed] [Google Scholar]
- Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y, Wada H, Seishima M, 2002. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect Immun 70 (2), 779–786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuglewicz AJ, Piotrowski P, Stodolak A, 2017. Relationship between toxoplasmosis and schizophrenia: A review. Adv Clin Exp Med 26 (6), 1031–1036. [DOI] [PubMed] [Google Scholar]
- Gaskell EA, Smith JE, Pinney JW, Westhead DR, McConkey GA, 2009. A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One 4 (3), e4801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghahremani DG, Lee B, Robertson CL, Tabibnia G, Morgan AT, De Shetler N, Brown AK, Monterosso JR, Aron AR, Mandelkern MA, Poldrack RA, London ED, 2012. Striatal dopamine D(2)/D(3) receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci 32 (21), 7316–7324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graham JE, Robles TF, Kiecolt-Glaser JK, Malarkey WB, Bissell MG, Glaser R, 2006. Hostility and pain are related to inflammation in older adults. Brain Behav Immun 20 (4), 389–400. [DOI] [PubMed] [Google Scholar]
- Hamilton KR, Mitchell MR, Wing VC, Balodis IM, Bickel WK, Fillmore M, Lane SD, Lejuez CW, Littlefield AK, Luijten M, Mathias CW, Mitchell SH, Napier TC, Reynolds B, Schutz CG, Setlow B, Sher KJ, Swann AC, Tedford SE, White MJ, Winstanley CA, Yi R, Potenza MN, Moeller FG, 2015. Choice impulsivity: Definitions, measurement issues, and clinical implications. Personal Disord 6 (2), 182–198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haroon E, Raison CL, Miller AH, 2012. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37 (1), 137–162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hinze-Selch D, Daubener W, Erdag S, Wilms S, 2010. The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol (Praha) 57 (2), 129–135. [DOI] [PubMed] [Google Scholar]
- Hoekstra R, van den Broek WW, Fekkes D, Bruijn JA, Mulder PG, Pepplinkhuizen L, 2001. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression. Psychiatry Res 103 (2–3), 115–123. [DOI] [PubMed] [Google Scholar]
- Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L, 2011. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 25 (2), 335–339. [DOI] [PubMed] [Google Scholar]
- Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R, 2012. The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog 8 (5), e1002704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jonah BA, Thiessen R, Au-Yeung E, 2001. Sensation seeking, risky driving and behavioral adaptation. Accid Anal Prev 33 (5), 679–684. [DOI] [PubMed] [Google Scholar]
- Kaufman S, 1971. The phenylalanine hydroxylating system from mammalian liver. Adv Enzymol Relat Areas Mol Biol 35, 245–319. [DOI] [PubMed] [Google Scholar]
- Kayser AS, Allen DC, Navarro-Cebrian A, Mitchell JM, Fields HL, 2012. Dopamine, corticostriatal connectivity, and intertemporal choice. J Neurosci 32 (27), 9402–9409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kocazeybek B, Oner YA, Turksoy R, Babur C, Cakan H, Sahip N, Unal A, Ozaslan A, Kilic S, Saribas S, Aslan M, Taylan A, Koc S, Dirican A, Uner HB, Oz V, Ertekin C, Kucukbasmaci O, Torun MM, 2009. Higher prevalence of toxoplasmosis in victims of traffic accidents suggest increased risk of traffic accident in Toxoplasma-infected inhabitants of Istanbul and its suburbs. Forensic Sci Int 187 (1–3), 103–108. [DOI] [PubMed] [Google Scholar]
- Kovacsics CE, Gottesman II, Gould TD, 2009. Lithium’s antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annu Rev Pharmacol Toxicol 49, 175–198. [DOI] [PubMed] [Google Scholar]
- Kruesi MJ, Rapoport JL, Hamburger S, Hibbs E, Potter WZ, Lenane M, Brown GL, 1990. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch Gen Psychiatry 47 (5), 419–426. [DOI] [PubMed] [Google Scholar]
- Kubera M, Kenis G, Bosmans E, Zieba A, Dudek D, Nowak G, Maes M, 2000. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol 52 (3), 237–241. [PubMed] [Google Scholar]
- Laget J, Plancherel B, Stephan P, Bolognini M, Corcos M, Jeammet P, Halfon O, 2006. Personality and repeated suicide attempts in dependent adolescents and young adults. Crisis 27 (4), 164–171. [DOI] [PubMed] [Google Scholar]
- Linderholm KR, Alm MT, Larsson MK, Olsson SK, Goiny M, Hajos M, Erhardt S, Engberg G, 2016. Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons. Neuropharmacology 102, 42–47. [DOI] [PubMed] [Google Scholar]
- Lindova J, Kubena AA, Sturcova H, Krivohlava R, Novotna M, Rubesova A, Havlicek J, Kodym P, Flegr J, 2010. Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes. Folia Parasitol (Praha) 57 (2), 136–142. [PubMed] [Google Scholar]
- Lindova J, Novotna M, Havlicek J, Jozifkova E, Skallova A, Kolbekova P, Hodny Z, Kodym P, Flegr J, 2006. Gender differences in behavioural changes induced by latent toxoplasmosis. Int J Parasitol 36 (14), 1485–1492. [DOI] [PubMed] [Google Scholar]
- Ling VJ, Lester D, Mortensen PB, Langenberg PW, Postolache TT, 2011. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 199 (7), 440–444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luijten M, Veltman DJ, Hester R, Smits M, Nijs IM, Pepplinkhuizen L, Franken IH, 2013. The role of dopamine in inhibitory control in smokers and non-smokers: a pharmacological fMRI study. Eur Neuropsychopharmacol 23 (10), 1247–1256. [DOI] [PubMed] [Google Scholar]
- Lund-Sorensen H, Benros ME, Madsen T, Sorensen HJ, Eaton WW, Postolache TT, Nordentoft M, Erlangsen A, 2016. A Nationwide Cohort Study of the Association Between Hospitalization With Infection and Risk of Death by Suicide. JAMA Psychiatry 73 (9), 912–919. [DOI] [PubMed] [Google Scholar]
- Malloy-Diniz LF, Lage GM, Campos SB, de Paula JJ, de Souza Costa D, Romano-Silva MA, de Miranda DM, Correa H, 2013. Association between the Catechol O-methyltransferase (COMT) Val158met polymorphism and different dimensions of impulsivity. PLoS One 8 (9), e73509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mann JJ, Arango VA, Avenevoli S, Brent DA, Champagne FA, Clayton P, Currier D, Dougherty DM, Haghighi F, Hodge SE, Kleinman J, Lehner T, McMahon F, Moscicki EK, Oquendo MA, Pandey GN, Pearson J, Stanley B, Terwilliger J, Wenzel A, 2009. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry 65 (7), 556–563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin HL, Alsaady I, Howell G, Prandovszky E, Peers C, Robinson P, McConkey GA, 2015. Effect of parasitic infection on dopamine biosynthesis in dopaminergic cells. Neuroscience 306, 50–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Massa NM, Duncan E, Jovanovic T, Kerley K, Weng L, Gensler L, Lee SS, Norrholm S, Powers A, Almli LM, Gillespie CF, Ressler K, Pearce BD, 2017. Relationship between Toxoplasma gondii seropositivity and acoustic startle response in an inner-city population. Brain Behav Immun 61, 176–183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mathai AJ, Lowry CA, Cook TB, Brenner LA, Brundin L, Groer MW, Peng X, Giegling I, Hartmann AM, Konte B, Friedl M, Fuchs D, Rujescua D, Postolachea TT, 2016. Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine – tyrosine ratio of their associations with trait aggression. Pteridines 27 (3–4), 77–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matuskey D, Luo X, Zhang S, Morgan PT, Abdelghany O, Malison RT, Li CS, 2013. Methylphenidate remediates error-preceding activation of the default mode brain regions in cocaine-addicted individuals. Psychiatry Res 214 (2), 116–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McConkey GA, Martin HL, Bristow GC, Webster JP, 2013. Toxoplasma gondii infection and behaviour - location, location, location? J Exp Biol 216 (Pt 1), 113–119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McNally L, Bhagwagar Z, Hannestad J, 2008. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 13 (6), 501–510. [DOI] [PubMed] [Google Scholar]
- Miller AH, Maletic V, Raison CL, 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65 (9), 732–741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller AH, Raison CL, 2016. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16 (1), 22–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B, 2011. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70 (7), 663–671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitchell MR, Potenza MN, 2014. Recent Insights into the Neurobiology of Impulsivity. Curr Addict Rep 1 (4), 309–319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC, 2001. Psychiatric aspects of impulsivity. Am J Psychiatry 158 (11), 1783–1793. [DOI] [PubMed] [Google Scholar]
- Nagineni CN, Pardhasaradhi K, Martins MC, Detrick B, Hooks JJ, 1996. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect Immun 64 (10), 4188–4196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O, 2013. Neuroinflammation and psychiatric illness. J Neuroinflammation 10, 43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nandam LS, Hester R, Wagner J, Dean AJ, Messer C, Honeysett A, Nathan PJ, Bellgrove MA, 2013. Dopamine D(2) receptor modulation of human response inhibition and error awareness. J Cogn Neurosci 25 (4), 649–656. [DOI] [PubMed] [Google Scholar]
- Neurauter G, Grahmann AV, Klieber M, Zeimet A, Ledochowski M, Sperner-Unterweger B, Fuchs D, 2008a. Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Cancer Lett 272 (1), 141–147. [DOI] [PubMed] [Google Scholar]
- Neurauter G, Scholl-Burgi S, Haara A, Geisler S, Mayersbach P, Schennach H, Fuchs D, 2013. Simultaneous measurement of phenylalanine and tyrosine by high performance liquid chromatography (HPLC) with fluorescence detection. Clin Biochem 46 (18), 1848–1851. [DOI] [PubMed] [Google Scholar]
- Neurauter G, Schrocksnadel K, Scholl-Burgi S, Sperner-Unterweger B, Schubert C, Ledochowski M, Fuchs D, 2008b. Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab 9 (7), 622–627. [DOI] [PubMed] [Google Scholar]
- Nicholas J, 2005. Human gammaherpesvirus cytokines and chemokine receptors. J Interferon Cytokine Res 25 (7), 373–383. [DOI] [PubMed] [Google Scholar]
- Okuno A, Fukuwatari T, Shibata K, 2011. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum. J Neurochem 118 (5), 796–805. [DOI] [PubMed] [Google Scholar]
- Okusaga O, Duncan E, Langenberg P, Brundin L, Fuchs D, Groer MW, Giegling I, Stearns-Yoder KA, Hartmann AM, Konte B, Friedl M, Brenner LA, Lowry CA, Rujescu D, Postolache TT, 2016. Combined Toxoplasma gondii seropositivity and high blood kynurenine--Linked with nonfatal suicidal self-directed violence in patients with schizophrenia. J Psychiatr Res 72, 74–81. [DOI] [PubMed] [Google Scholar]
- Okusaga O, Langenberg P, Sleemi A, Vaswani D, Giegling I, Hartmann AM, Konte B, Friedl M, Groer MW, Yolken RH, Rujescu D, Postolache TT, 2011. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res 133 (1–3), 150–155. [DOI] [PubMed] [Google Scholar]
- Okusaga O, Muravitskaja O, Fuchs D, Ashraf A, Hinman S, Giegling I, Hartmann AM, Konte B, Friedl M, Schiffman J, Hong E, Reeves G, Groer M, Dantzer R, Rujescu D, Postolache TT, 2014. Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality? PLoS One 9 (1), e85945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oquendo MA, Galfalvy H, Russo S, Ellis SP, Grunebaum MF, Burke A, Mann JJ, 2004. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 161 (8), 1433–1441. [DOI] [PubMed] [Google Scholar]
- Oswald LM, Wong DF, Zhou Y, Kumar A, Brasic J, Alexander M, Ye W, Kuwabara H, Hilton J, Wand GS, 2007. Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage 36 (1), 153–166. [DOI] [PubMed] [Google Scholar]
- Paaver M, Nordquist N, Parik J, Harro M, Oreland L, Harro J, 2007. Platelet MAO activity and the 5-HTT gene promoter polymorphism are associated with impulsivity and cognitive style in visual information processing. Psychopharmacology (Berl) 194 (4), 545–554. [DOI] [PubMed] [Google Scholar]
- Pappas G, Roussos N, Falagas ME, 2009. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39 (12), 1385–1394. [DOI] [PubMed] [Google Scholar]
- Parlog A, Schluter D, Dunay IR, 2015. Toxoplasma gondii-induced neuronal alterations. Parasite Immunol 37 (3), 159–170. [DOI] [PubMed] [Google Scholar]
- Patel A, Siegel A, Zalcman SS, 2010. Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav Immun 24 (8), 1276–1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pearce BD, Kruszon-Moran D, Jones JL, 2012. The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol Psychiatry 72 (4), 290–295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT, 2012. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry 69 (11), 1123–1130. [DOI] [PubMed] [Google Scholar]
- Perry JL, Carroll ME, 2008. The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) 200 (1), 1–26. [DOI] [PubMed] [Google Scholar]
- Pesce M, Speranza L, Franceschelli S, Ialenti V, Patruno A, Febo MA, De Lutiis MA, Felaco M, Grilli A, 2011. Biological role of interleukin-1beta in defensive-aggressive behaviour. J Biol Regul Homeost Agents 25 (3), 323–329. [PubMed] [Google Scholar]
- Pezze MA, Dalley JW, Robbins TW, 2009. Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2/3) receptor antagonist sulpiride. Psychopharmacology (Berl) 202 (1–3), 307–313. [DOI] [PubMed] [Google Scholar]
- Pfefferkorn ER, 1984. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A 81 (3), 908–912. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ploder M, Neurauter G, Spittler A, Schroecksnadel K, Roth E, Fuchs D, 2008. Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations. Amino Acids 35 (2), 303–307. [DOI] [PubMed] [Google Scholar]
- Pompili M, Serafini G, Innamorati M, Dominici G, Ferracuti S, Kotzalidis GD, Serra G, Girardi P, Janiri L, Tatarelli R, Sher L, Lester D, 2010. Suicidal behavior and alcohol abuse. Int J Environ Res Public Health 7 (4), 1392–1431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Postolache TT, Cook TB, 2013. Is latent infection with Toxoplasma gondii a risk factor for suicidal behavior? Expert Rev Anti Infect Ther 11 (4), 339–342. [DOI] [PubMed] [Google Scholar]
- Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E, 2008. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63 (8), 801–808. [DOI] [PubMed] [Google Scholar]
- Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA, 2011. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One 6 (9), e23866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rao ML, Gross G, Strebel B, Braunig P, Huber G, Klosterkotter J, 1990. Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res 34 (3), 243–257. [DOI] [PubMed] [Google Scholar]
- Retz W, Rosler M, Supprian T, Retz-Junginger P, Thome J, 2003. Dopamine D3 receptor gene polymorphism and violent behavior: relation to impulsiveness and ADHD-related psychopathology. J Neural Transm (Vienna) 110 (5), 561–572. [DOI] [PubMed] [Google Scholar]
- Roberti JW, 2004. A review of behavioral and biological correlates of sensation seeking. J Res Pers 38 (3), 256–279. [Google Scholar]
- Roberti JW, Storch EA, Bravata E, 2003. Further psychometric support for the Sensation Seeking Scale--Form V. J Pers Assess 81 (3), 291–292. [DOI] [PubMed] [Google Scholar]
- Saklayen SS, Mabrouk OS, Pehek EA, 2004. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. J Pharmacol Exp Ther 311 (1), 342–348. [DOI] [PubMed] [Google Scholar]
- Samojlowicz D, Borowska-Solonynko A, Golab E, 2013. Prevalence of Toxoplasma gondii parasite infection among people who died due to sudden death in the capital city of Warsaw and its vicinity. Przegl Epidemiol 67 (1), 29–33, 115–118. [PubMed] [Google Scholar]
- Sharma L, Markon KE, Clark LA, 2014. Toward a theory of distinct types of “impulsive” behaviors: A meta-analysis of self-report and behavioral measures. Psychol Bull 140 (2), 374–408. [DOI] [PubMed] [Google Scholar]
- Silva NM, Rodrigues CV, Santoro MM, Reis LF, Alvarez-Leite JI, Gazzinelli RT, 2002. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect Immun 70 (2), 859–868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simon NW, Beas BS, Montgomery KS, Haberman RP, Bizon JL, Setlow B, 2013. Prefrontal cortical-striatal dopamine receptor mRNA expression predicts distinct forms of impulsivity. Eur J Neurosci 37 (11), 1779–1788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Skallova A, Kodym P, Frynta D, Flegr J, 2006. The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology 133 (Pt 5), 525–535. [DOI] [PubMed] [Google Scholar]
- Soyka M, 2011. Neurobiology of aggression and violence in schizophrenia. Schizophr Bull 37 (5), 913–920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spellberg B, Edwards JE Jr., 2001. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 32 (1), 76–102. [DOI] [PubMed] [Google Scholar]
- Stibbs HH, 1985. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 79 (2), 153–157. [DOI] [PubMed] [Google Scholar]
- Suarez EC, 2003. Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom Med 65 (4), 523–527. [DOI] [PubMed] [Google Scholar]
- Suarez EC, Lewis JG, Krishnan RR, Young KH, 2004. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 29 (9), 1119–1128. [DOI] [PubMed] [Google Scholar]
- Sugden K, Moffitt TE, Pinto L, Poulton R, Williams BS, Caspi A, 2016. Is Toxoplasma gondii Infection Related to Brain and Behavior Impairments in Humans? Evidence from a Population-Representative Birth Cohort. PLoS One 11 (2), e0148435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutterland AL, Fond G, Kuin A, Koeter MW, Lutter R, van Gool T, Yolken R, Szoke A, Leboyer M, de Haan L, 2015. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr Scand 132 (3), 161–179. [DOI] [PubMed] [Google Scholar]
- Swann AC, Lijffijt M, Lane SD, Steinberg JL, Moeller FG, 2009. Increased trait-like impulsivity and course of illness in bipolar disorder. Bipolar Disord 11 (3), 280–288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Swerdlow NR, Braff DL, Geyer MA, Koob GF, 1986. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry 21 (1), 23–33. [DOI] [PubMed] [Google Scholar]
- Tan D, Soh LJ, Lim LW, Daniel TC, Zhang X, Vyas A, 2015. Infection of male rats with Toxoplasma gondii results in enhanced delay aversion and neural changes in the nucleus accumbens core. Proc Biol Sci 282 (1808), 20150042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tan D, Vyas A, 2016. Toxoplasma gondii infection and testosterone congruently increase tolerance of male rats for risk of reward forfeiture. Horm Behav 79, 37–44. [DOI] [PubMed] [Google Scholar]
- Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, Aseffa A, Mihret W, Abebe M, Alem A, Medhin G, Habte A, 2011. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J 49 (3), 211–220. [PubMed] [Google Scholar]
- Torrey EF, Bartko JJ, Yolken RH, 2012. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 38 (3), 642–647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trimpop RM, Kerr JH, Kirkcaldy B, 1998. Comparing personality constructs of risk-taking behavior. Pers Individ Dif 26 (2), 237–254. [Google Scholar]
- Turecki G, 2005. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci 30 (6), 398–408. [PMC free article] [PubMed] [Google Scholar]
- van Gaalen MM, Brueggeman RJ, Bronius PF, Schoffelmeer AN, Vanderschuren LJ, 2006. Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) 187 (1), 73–85. [DOI] [PubMed] [Google Scholar]
- van Spronsen FJ, Hoeksma M, Reijngoud DJ, 2009. Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32 (1), 46–51. [DOI] [PubMed] [Google Scholar]
- Volavka J, Citrome L, 2011. Pathways to aggression in schizophrenia affect results of treatment. Schizophr Bull 37 (5), 921–929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Voon V, Reynolds B, Brezing C, Gallea C, Skaljic M, Ekanayake V, Fernandez H, Potenza MN, Dolan RJ, Hallett M, 2010. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) 207 (4), 645–659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Webster JP, Lamberton PH, Donnelly CA, Torrey EF, 2006. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii’s ability to alter host behaviour. Proc Biol Sci 273 (1589), 1023–1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wei J, Xu H, Ramchand CN, Hemmings GP, 1995. Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset. Schizophr Res 14 (3), 257–260. [DOI] [PubMed] [Google Scholar]
- Werner ER, Blau N, Thony B, 2011. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 438 (3), 397–414. [DOI] [PubMed] [Google Scholar]
- Wilson LC, Scarpa A, 2013. Baseline heart rate, sensation seeking, and aggression in young adult women: a two-sample examination. Aggress Behav 39 (4), 280–289. [DOI] [PubMed] [Google Scholar]
- Wu HQ, Rassoulpour A, Schwarcz R, 2007. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm (Vienna) 114 (1), 33–41. [DOI] [PubMed] [Google Scholar]
- Wurtman RJ, Rose CM, Chou C, Larin FF, 1968. Daily rhythms in the concentrations of various amino acids in human plasma. N Engl J Med 279 (4), 171–175. [DOI] [PubMed] [Google Scholar]
- Xiao J, Li Y, Prandovszky E, Karuppagounder SS, Talbot CC Jr., Dawson VL, Dawson TM, Yolken RH, 2014. MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience 268, 128–138. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xu S, Das G, Hueske E, Tonegawa S, 2017. Dorsal Raphe Serotonergic Neurons Control Intertemporal Choice under Trade-off. Curr Biol 27 (20), 3111–3119e3113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yagmur F, Yazar S, Temel HO, Cavusoglu M, 2010. May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int 199 (1–3), 15–17. [DOI] [PubMed] [Google Scholar]
- Yereli K, Balcioglu IC, Ozbilgin A, 2006. Is Toxoplasma gondii a potential risk for traffic accidents in Turkey? Forensic Sci Int 163 (1–2), 34–37. [DOI] [PubMed] [Google Scholar]
- Zalcman SS, Siegel A, 2006. The neurobiology of aggression and rage: role of cytokines. Brain Behav Immun 20 (6), 507–514. [DOI] [PubMed] [Google Scholar]
- Zangerle R, Kurz K, Neurauter G, Kitchen M, Sarcletti M, Fuchs D, 2010. Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy. Brain Behav Immun 24 (3), 403–408. [DOI] [PubMed] [Google Scholar]
- Zhang Y, Traskman-Bendz L, Janelidze S, Langenberg P, Saleh A, Constantine N, Okusaga O, Bay-Richter C, Brundin L, Postolache TT, 2012. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin Psychiatry 73 (8), 1069–1076. [DOI] [PubMed] [Google Scholar]
- Zuckerman M, 1994. Behavioral expressions and biosocial bases of sensation seeking. Cambridge Univ. Press, Cambridge, UK. [Google Scholar]
- Zuckerman M, Neeb M, 1979. Sensation seeking and psychopathology. Psychiatry Res 1 (3), 255–264. [DOI] [PubMed] [Google Scholar]